QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
NASDAQ:APVO

Aptevo Therapeutics - APVO Price Target & Analyst Ratings

$2.30
+0.02 (+0.88%)
(As of 01/31/2023 05:19 PM ET)
Add
Compare
Today's Range
$2.25
$2.39
50-Day Range
$2.00
$3.91
52-Week Range
$1.94
$7.55
Volume
118,756 shs
Average Volume
108,738 shs
Market Capitalization
$11.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00

Aptevo Therapeutics Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

N/A
Based on 0 Analyst Ratings

Consensus Analyst Price Target

$13.00
465.22% Upside
High Prediction$13.00
Average Prediction$13.00
Low Prediction$13.00
TypeCurrent
1/31/22 to 1/31/23
1 Month Ago
1/1/22 to 1/1/23
3 Months Ago
11/2/21 to 11/2/22
1 Year Ago
1/31/21 to 1/31/22
Consensus RatingN/AN/A
Moderate Buy
Moderate Buy
Strong Buy N/A N/A
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy N/A N/A
1 Buy rating(s)
1 Buy rating(s)
Hold N/A N/A
1 Hold rating(s)
1 Hold rating(s)
Sell N/A N/A
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.00$13.00$24.50$36.00
Predicted Upside465.22% Upside180.17% Upside163.25% Upside209.28% Upside
Get Aptevo Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for APVO and its competitors with MarketBeat's FREE daily newsletter.


APVO Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

APVO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Aptevo Therapeutics Stock vs. The Competition

TypeAptevo TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
0.00
2.65
2.46
Consensus RatingN/ABuyHold
Predicted Upside470.18% Upside957.94% Upside10.99% Upside
News Sentiment RatingPositive News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/12/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$20.00 ➝ $13.00+180.17%
12/22/2021UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
11/15/2021Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jonathan Aschoff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy$50.00 ➝ $36.00+209.28%
(Data available from 1/31/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












APVO Price Target - Frequently Asked Questions

Does Aptevo Therapeutics's stock price have much upside?

According to analysts, Aptevo Therapeutics's stock has a predicted upside of 180.17% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:APVO) was last updated on 1/31/2023 by MarketBeat.com Staff